Larry Dobrow

Most Recent Articles by Larry Dobrow

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

Drugmakers like Merck are making a big education push as they lay the groundwork for future biosimilars.

What do physicians think about biosimilars?

What do physicians think about biosimilars?

A Sermo poll asked physicians: Do you feel biosimilars will prove safe and effective enough for you to prescribe them when more become available?"

Post Pfizer, Allergan faces the future

Post Pfizer, Allergan faces the future

Mere days after the Pfizer deal collapsed, top Allergan executives had nary an air of regret about them.

Spending on drugs is up, but by how much?

Spending on drugs is up, but by how much?

Total medicine spending surged to $424.8 billion in 2015, representing an increase of 12.2%. Here's why that growth figure is closer to 2.9%.

Be a better mentor, says Baxalta's Leonardi

Be a better mentor, says Baxalta's Leonardi

Too often left undiscussed is that a powerful business case can be made for more frequent and focused mentorship.

More Articles by Larry Dobrow

OPINION

Email Newsletters